StonvexLoading…
StonvexCore line items from DE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-05-03 | Q1 2026 2026-02-01 | Annual 2025 2025-11-02 | Q3 2025 2025-07-27 |
|---|---|---|---|---|
Revenue | $22.98B | $9.61B | $45.68B | $33.29B |
Operating Income | $3.13B | $836.00M | $6.26B | $4.83B |
Net Income | $2.43B | $656.00M | $5.03B | $3.96B |
EPS (Diluted) | $8.97 | $2.42 | $18.50 | $14.57 |
Total Assets | $107.00B | $103.44B | $106.00B | $107.82B |
Total Liabilities | $79.54B | $77.08B | $79.99B | $82.55B |
Cash & Equivalents | $7.91B | $6.80B | $8.28B | $8.58B |
Free Cash Flow OCF − CapEx | $591.00M | $-1.15B | $6.10B | $2.61B |
Shares Outstanding | 270.90M | 270.90M | 270.40M | 271.90M |